Trial intelligence / Profile preview

Microbotox techniques for treatment of dilated facial pores

IRCT20211010052723N2Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jul 2022
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of neuronox in Enlarged facial pores (2 arms), sponsored by Isfahan University of Medical Sciences. Started Jul 2022; status: completed.

02

Drugs

neuronox
03

Conditions

Enlarged facial pores

Beyond the preview

Go deeper on IRCT20211010052723N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211010052723N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call